Foghorn Therapeutics (FHTX) Earnings Date & Reports
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FHTX is expected to report earnings to -24 cents per share on March 05
Q4'25
Est.
$-0.25
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.11
Q4'24
Beat
by $0.12
The last earnings report on November 05 showed earnings per share of -25 cents, beating the estimate of -33 cents. With 165.23K shares outstanding, the current market capitalization sits at 333.04M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FHTX showed earnings on November 05, 2025. You can read more about the earnings report here.